drugset / Trial / NCT03839238
Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury
NaSingle-groupOpen-labelTreatment
Summary
human embryonic stem cell derived mesenchymal stem cells like cell for the meniscus injury, and observe the safety of the cells for meniscus injury
Timeline
- Start
- 2019-01-04
- Primary completion
- 2020-06-30
- Completion
- 2020-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hESC derived MSC like cell | Cell therapy | — | — |
Indications
No indication recorded.